Seeking Alpha

Mylan (MYL +1%) gains on an upgrade to Buy from at Goldman, citing improved earnings visibility...

Mylan (MYL +1%) gains on an upgrade to Buy from at Goldman, citing improved earnings visibility and an underestimated margin expansion led by the company's EpiPen product mix shift.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs